Codexis, Inc.

Codexis, Inc., incorporated on January 31, 2002, is a protein engineering company. The Company is engaged in the development of biocatalysts for the commercial manufacture of pharmaceuticals and fine chemicals. The Company operates through its two segments, such as the performance enzymes and novel biotherapeutics. It provides enzyme optimization services from small scale through to commercial quantities and also develops biocatalyst products. It is also engaged in the development of manufacturing processes for active pharmaceutical ingredients, fine chemicals and food ingredients.The Company’s CodeEvolver is a protein engineering technology platform and products in the pharmaceuticals market. The Company serves various industries, including food and food ingredients, animal feed, flavors, fragrances, and agricultural chemical. It also uses its technology to develop enzyme for customers using next generation sequencing (NGS) and polymerase chain reaction (PCR/qPCR) for in vitro molecular diagnostic and genomic research applications.

Bank Name Codexis, Inc.
Stock Exchange NASDAQ
Symbol CDXS
Sector Healthcare
Industry Major Chemicals
Country United States
World Region Amarica
CEO Mr. John J. Nicols
Employees 116
Registered Year 2002